vs
Side-by-side financial comparison of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and NOVARTIS AG (NVS). Click either name above to swap in a different company.
Ascentage Pharma Group International is a global clinical-stage biotechnology company specializing in developing novel targeted therapies for cancers, chronic viral infections, and age-related diseases. It focuses on small molecule drugs targeting apoptosis pathways and other key oncogenic mechanisms, with operations spanning China, the U.S., and other global markets, serving patients with unmet medical needs worldwide.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $574.1K | — | ||
| Q2 25 | $32.6M | — |
| Q4 25 | — | — | ||
| Q2 25 | $11.4M | — |
| Q4 25 | — | — | ||
| Q2 25 | 90.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
